Mental Disorders: all 2,148 studies
Page 20 of 22. Open to participants first (425), then studies with results posted, then the rest; newest registration first within each.
- Relationship Between Treatment With Bach´s Flower Remedy and Spiritual Well-Being of People With Common Mental DisorderCompletedNCT01324674Phase 2
- Multi-site Communication Deficits in SchizophreniaCompletedNCT01317121
- Forensic Assertive Community Treatment: An Emerging Model of Service DeliveryCompletedNCT01313052Phase 3
- Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesTerminatedNCT01310140
- Yoga in an Urban School for Children With Emotional Behavioral DisordersCompletedNCT01305876Not applicable
- Metabolic Side-effects for Second-generation AntipsychoticsCompletedNCT01280396
- Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) PatientsTerminatedNCT01246310Not applicable
- The Right Question Project-Mental Health: An Intervention to Increase Engagement and Retention in Mental Health CareCompletedNCT01226329Not applicable
- Multi-disciplinary Treatment for Patients Experiencing First Episode of PsychosisCompletedNCT01216891Not applicable
- Psychological Treatment of Overweight Binge EatersCompletedNCT01208272Phase 1/2
- The Psychological Treatment of Overweight Binge Eaters Minority SupplementCompletedNCT01208259Phase 1/2
- Optimal Duration of Early Intervention for PsychosisStatus unknownNCT01202357Not applicable
- Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHDCompletedNCT01201187Phase 3
- Duration of Untreated Psychosis (DUP) and Pathways to Care in NordlandCompletedNCT01196858
- Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset PsychosisCompletedNCT01196286Not applicable
- Reduction of Cardiovascular Risk in Severe Mental IllnessStatus unknownNCT01182012Phase 4
- Can Psychotherapy Reduce Sickness Absence?Status unknownNCT01181635Not applicable
- HIV/AIDS, Severe Mental Illness and HomelessnessCompletedNCT01172704Phase 2
- Impact of Family Psychoeducation on PsychosisStatus unknownNCT01172106Not applicable
- Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy ControlsCompletedNCT01162434
- Efficacy and Safety of Paliperidone ER in First Episode PsychosisCompletedNCT01157585Phase 4
- Efficacy and Safety With Ziprasidone in First-episode PsychosisCompletedNCT01157559Phase 4
- Cognitive Behaviour Therapy and Cognitive Training in Work Rehabilitation for Persons With Severe Mental IllnessCompletedNCT01139502Not applicable
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to RisperidoneCompletedNCT01119638Phase 4
- Tolerance and Effect of Antipsychotics in Children and Adolescents With PsychosisCompletedNCT01119014Phase 4
- Treatment of Metabolic Syndrome in a Community Mental Health CenterCompletedNCT01115114Not applicable
- Prevention of Weight Gain in Early PsychosesCompletedNCT01075295Not applicable
- Influence of Oxytocin on the Startle Reflex and on Its ModulationStatus unknownNCT01066299Not applicable
- Neuroimaging Studies of Neurophysiological Phenotypes in SchizophreniaCompletedNCT01036568
- Cognitive Skills Training Using Computer for Patients With Severe Mental IllnessCompletedNCT01036282Phase 4
- Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)CompletedNCT01027962Not applicable
- Efficacy and Safety of Aripiprazole in First Episode PsychosisCompletedNCT01026584Phase 4
- Paternal Psychosis After Baby BornCompletedNCT01011088
- 6-Year Follow-up of a Prevention Program for Bereaved FamiliesCompletedNCT01008189Phase 3
- Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following PsychosisCompletedNCT01003132Not applicable
- Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute PsychiatryStatus unknownNCT00986167Phase 4
- Effects of Delta-9-THC and Iomazenil in Healthy HumansCompletedNCT00982982Early Phase 1
- The Epidemiological Study on Psychiatric Disorders and Psychotropic DrugsStatus unknownNCT00982943
- Medication Adherence in Schizophrenia: Development of a CBT-Based InterventionCompletedNCT00980252Not applicable
- Introduction Seminar About Patient Participation and Treatment Options for Psychiatric Patients on Waiting ListCompletedNCT00967265Not applicable
- Supported Employment in a Swedish ContextStatus unknownNCT00960024Phase 2
- Risk Factors for Psychiatric Disorders Associated With Adolescent Idiopathic ScoliosisWithdrawnNCT00958373
- Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental DisorderCompletedNCT00942097Phase 2/3
- Stage-specific Case Management for Early PsychosisCompletedNCT00919620Not applicable
- Role of Minocycline in First Episode PsychosisCompletedNCT00916461Phase 1/2
- Extended Specialized Assertive Intervention for First Episode PsychosisCompletedNCT00914238Not applicable
- Quality Project to Evaluate and Validate the FAST-O Rating ScaleCompletedNCT00913731
- Cognitive Training to Improve Work Outcomes in Severe Mental IllnessCompletedNCT00895258Phase 2
- Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior ProblemsCompletedNCT00889538Not applicable
- An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)CompletedNCT00878462Phase 2
- Risk Factors for Postpartum PsychosisCompletedNCT00872313
- Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in SchizophreniaCompletedNCT00859872Phase 4
- Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)CompletedNCT00844922Phase 2
- Cognitive Training to Enhance VA Work Program OutcomesCompletedNCT00829400Not applicable
- RBD Longitudinal as Prognostic for PDActive, not recruitingNCT00817726
- A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)CompletedNCT00798395Phase 1
- Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral TherapyCompletedNCT00791440Not applicable
- Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic TreatmentStatus unknownNCT00789022
- Ziprasidone vs Standard Therapy for Agitated Patients in the EDWithdrawnNCT00786318Phase 4
- CYP2D6 Pharmacogenetics in Risperidone-Treated ChildrenCompletedNCT00783783
- Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset SchizophreniaTerminatedNCT00757497Phase 1
- Quetiapine in the Treatment of Psychotic Depression - a Pilot StudyCompletedNCT00751504Phase 3
- Treatment of Hepatitis C in Psychiatric PatientsCompletedNCT00751426
- Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest PainStatus unknownNCT00736346Not applicable
- A Randomized Controlled Trial of Individual Therapy for First Episode PsychosisStatus unknownNCT00722163Early Phase 1
- Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.CompletedNCT00716755Not applicable
- Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental IllnessCompletedNCT00714818Phase 3
- Impact of Genetic Counseling for Individuals With Mental IllnessCompletedNCT00713804Phase 3
- Behavioral Intervention to Reduce Novel Antipsychotic Medication Health RisksCompletedNCT00709345Phase 1/2
- Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)WithdrawnNCT00702793Phase 4
- Social Competence Training for Adolescents With Borderline Intellectual FunctioningCompletedNCT00692081Phase 2/3
- Genetics of Symptomatology and Treatment Response in Psychotic Major DepressionCompletedNCT00691535
- Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune MechanismsCompletedNCT00690196Not applicable
- An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)CompletedNCT00690131Not applicable
- Development of a Family-Based Treatment for Adolescent Methamphetamine UseCompletedNCT00680511Phase 1
- Ziprasidone for Severe Conduct and Other Disruptive Behavior DisordersCompletedNCT00676429Phase 2
- Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative StudyCompletedNCT00670371
- Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental IllnessCompletedNCT00661869Not applicable
- Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for PsychosisCompletedNCT00655239Not applicable
- A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
- Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient AdmissionCompletedNCT00627510
- Detecting Risk of Suicide in a Pediatric Emergency DepartmentCompletedNCT00623493
- Treating Tobacco Dependence in Adolescents With Co-occurring Psychiatric DisordersCompletedNCT00618943Phase 3
- HIV, Abuse, and Psychiatric Disorders Among YouthCompletedNCT00603369Phase 1
- Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior DisordersCompletedNCT00600470Phase 1/2
- Development Of New Techniques For Functional Magnetic Resonance Imaging Of The BrainTerminatedNCT00593931Not applicable
- Clinical and Biological Characteristics of Psychotic DepressionCompletedNCT00576095
- Far Infrared Radiation Treatment of Dementia and Other Mental IllnessStatus unknownNCT00574054Phase 1
- Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than RisperidoneStatus unknownNCT00563017Not applicable
- Iron Supplementation of Marginally Low Birth Weight InfantsCompletedNCT00558454Phase 4
- Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic DisorderStatus unknownNCT00541502
- Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot StudyCompletedNCT00511277Phase 4
- Contingency Management for Smoking Cessation Among Veterans With Psychotic DisordersTerminatedNCT00508560Not applicable
- Enhancing Motivation To Quit Smoking In Smokers With Serious Mental IllnessCompletedNCT00500695Phase 1
- HIV Prevention for Youth With Severe Mental IllnessCompletedNCT00496691Phase 1
- Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental IllnessesCompletedNCT00494650Not applicable
- ACP-104 in Acutely Psychotic Subjects With SchizophreniaCompletedNCT00490516Phase 2
- FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTerminatedNCT00486798Phase 3
- Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and PsychosisCompletedNCT00484302Not applicable
- Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental IllnessCompletedNCT00474227Not applicable